Genital Herpes News and Research

RSS
Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

Vaginal silicone ring may protect women against HIV, herpes virus

Vaginal silicone ring may protect women against HIV, herpes virus

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

NanoViricides speeds up HerpeCide drug development program

NanoViricides speeds up HerpeCide drug development program

Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

GBD analysis shows over 95% of global population has health problems

GBD analysis shows over 95% of global population has health problems

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Men undergoing circumcision may be at increased risk of infecting female partners with HIV

Men undergoing circumcision may be at increased risk of infecting female partners with HIV

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

Common herpes drug Valacyclovir decreases HIV-1 levels

Common herpes drug Valacyclovir decreases HIV-1 levels

Scientists design a promising vaccine for herpes viruses

Scientists design a promising vaccine for herpes viruses

New type of vaccine holds promise for prevention of genital herpes

New type of vaccine holds promise for prevention of genital herpes

SLU investigators find promising candidates for new herpes virus treatments

SLU investigators find promising candidates for new herpes virus treatments

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

PaxVax partners with UC to develop combination vaccine to prevent genital HSV infections

Johns Hopkins researchers identify protein that regulates the body's immune response to CMV

Johns Hopkins researchers identify protein that regulates the body's immune response to CMV

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013